HOLOGIC INC (HOLX)

75.25 0.1 (0.14%)

As of 2026-02-17 19:58:08 EST

Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.

Traded asNasdaq: HOLX
ISINUS4364401012
CIK0000859737
LEI549300DYP6F5ZJL0LB74
EIN042902449
SectorMedical Technology
IndustryX-Ray Apparatus & Tubes & Related Irradiation Apparatus
CEOStephen P. MacMillan
Employees7,070
Fiscal Year End0928
Address250 CAMPUS DRIVE, MARLBOROUGH, MA, 01752
Phone5082632900
Websitehttps://www.hologic.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
HOLXHOLOGIC INC2026-02-17 19:58:0875.250.10.14
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
HOLX0000859737HOLOGIC INCUS4364401012549300DYP6F5ZJL0LB74042902449Nasdaq3844X-Ray Apparatus & Tubes & Related Irradiation Apparatus0928DE250 CAMPUS DRIVEMARLBOROUGHMA01752UNITED STATESUS5082632900250 CAMPUS DRIVE, MARLBOROUGH, MA, 01752250 CAMPUS DRIVE, MARLBOROUGH, MA, 01752—Medical Technology1985Stephen P. MacMillan7,070https://www.hologic.com/13,566,017,923302,940,000223,244,905Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.2026-02-12 15:52:34
This is a preview of the latest data. Subscribe to access the full data.
HOLX Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
HOLX Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202513,566,017,923-4,490,671,027-24.8698223,244,905-3,696,312-1.6288
202418,056,688,950-1,581,245,529-8.052226,941,217-13,061,585-5.4423
202319,637,934,479880,088,2084.6918240,002,802-5,830,957-2.3719
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Essex D. MitchellChief Operating Officer2024592,69201,944,766725,000196,2724,083,725
John M. GriffinGeneral Counsel2024644,23101,555,966550,000223,8583,474,051
Stephen P. MacmillanChief Executive Officer, Chairman, President20241,212,62809,141,4681,990,413537,27515,819,261
Karleen M. ObertonChief Financial Officer2024694,23101,944,766600,000226,4464,090,438
Jan VerstrekenGroup President2024693,39901,555,966611,323225,2113,585,895
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20257,070
20247,063
20236,990
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue—4,030,300,0004,030,400,000
Cost Of Revenue—39,200,000179,500,000
Gross Profit—2,227,800,0002,071,500,000
Research And Development Expenses—272,800,000294,300,000
General And Administrative Expenses—409,400,000392,400,000
Operating Expenses—1,345,200,0001,403,100,000
Operating Income—882,600,000668,400,000
Net Income—789,500,000456,000,000
Earnings Per Share Basic—3.351.85
Earnings Per Share Diluted—3.321.83
Weighted Average Shares Outstanding Basic—235,723,000246,772,000
Weighted Average Shares Outstanding Diluted—237,553,000248,831,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents—2,160,200,0002,722,500,000
Marketable Securities Current—173,400,000—
Accounts Receivable—600,400,000625,600,000
Inventories—679,800,000617,600,000
Non Trade Receivables—37,500,00033,000,000
Other Assets Current———
Total Assets Current—3,823,300,0004,184,500,000
Marketable Securities Non Current—96,400,000—
Property Plant And Equipment—537,800,000517,000,000
Other Assets Non Current—410,800,000267,900,000
Total Assets Non Current—5,332,700,0004,954,800,000
Total Assets—9,156,000,0009,139,300,000
Accounts Payable—203,800,000175,200,000
Deferred Revenue—212,900,000199,200,000
Short Term Debt—37,500,000287,000,000
Other Liabilities Current—579,700,000534,600,000
Total Liabilities Current—1,037,200,0001,207,300,000
Long Term Debt—2,534,600,0002,818,200,000
Other Liabilities Non Current—406,300,000334,600,000
Total Liabilities Non Current———
Total Liabilities———
Common Stock—3,000,0003,000,000
Retained Earnings—2,845,800,0002,056,300,000
Accumulated Other Comprehensive Income—-111,500,000-147,600,000
Total Shareholders Equity—5,130,000,0005,016,900,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization—209,700,000233,800,000
Share Based Compensation Expense—82,300,00079,600,000
Other Non Cash Income Expense—-45,900,000-28,900,000
Change In Accounts Receivable—-41,000,0001,500,000
Change In Inventories—47,400,0004,900,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable—22,200,000-23,000,000
Change In Other Liabilities—73,400,000-14,200,000
Cash From Operating Activities—1,285,200,0001,051,200,000
Purchases Of Marketable Securities—267,700,000—
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment—130,200,000150,200,000
Acquisition Of Business—297,300,0005,000,000
Other Investing Activities—2,000,0007,400,000
Cash From Investing Activities—-781,000,000-152,100,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock—835,100,000474,800,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt——0
Other Financing Activities—37,800,00043,000,000
Cash From Financing Activities—-1,108,600,000-483,200,000
Change In Cash—-595,500,000416,200,000
Cash At End Of Period—2,160,200,0002,722,500,000
Income Taxes Paid—137,900,000296,100,000
Interest Paid—117,100,000105,400,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share—3.351.85
Price To Earnings Ratio—24.125437.5135
Earnings Growth Rate—81.0811-64.2857
Price Earnings To Growth Ratio—0.2975-0.5835
Book Value Per Share—34.442132.143
Price To Book Ratio—2.34652.1591
Ebitda—1,259,200,0001,097,000,000
Enterprise Value—19,463,032,86017,508,676,800
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio—0.50140.6189
Capital Expenditures—230,500,000269,200,000
Free Cash Flow—1,054,700,000782,000,000
Return On Equity—0.15390.0909
One Year Beta0.32680.26510.7131
Three Year Beta0.4540.58140.6477
Five Year Beta0.52670.75460.8136
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Horvath Mark W.President, Breast & Skeletal2026-02-10113D23,026
De Walt DianaSVP, Human Resources2026-01-304,416D7,603
Schnittker BrandonPresident, GYN Surgical2025-12-1290D17,512
Liddy Anne M.General Counsel2025-11-14337D28,237
COHN BENJAMIN JORDANPrincipal Accounting Officer2025-11-14187D17,884
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Thomas R CarperSenator2023-02-02Sale (Full)2023-01-11Spouse$1,001 - $15,000
John F ReedSenator2019-03-18Sale (Full)2019-02-28Self$1,001 - $15,000
John F ReedSenator2018-12-12Purchase2018-11-28Self$1,001 - $15,000
Susan M CollinsSenator2018-06-12Sale (Full)2018-05-04Spouse$15,001 - $50,000
Susan M CollinsSenator2017-05-10Purchase2016-12-01Spouse$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Gilbert Cisneros2025-04-07CA31Sale2025-03-31—$1,001 - $15,000
Susie Lee2022-12-29NV03Sale2022-11-30Joint$1,001 - $15,000
Susie Lee2022-08-13NV03Purchase2021-09-30Joint$1,001 - $15,000
Tom Malinowski2021-03-06NJ07Sale2021-02-23—$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Abel Hall, LLC2025-12-31307,2714,12574.4899
Cetera Investment Advisers2025-12-311,678,78522,53774.4902
GUGGENHEIM CAPITAL LLC2025-12-31550,6307,39274.49
Caisse de depot et placement du Quebec2025-12-311,938,37926,02274.49
AMERICAN CAPITAL MANAGEMENT INC2025-12-311,212,69716,28074.49
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
EMPOWER FUNDS, INC.2025-12-31Institutional ClassMXUGX330,000325,238.440.0234
EMPOWER FUNDS, INC.2025-12-31Investor ClassMXLMX330,000325,238.440.0234
EMPOWER FUNDS, INC.2025-12-31Institutional ClassMXYKX229,60017,102,903.940.8502
EMPOWER FUNDS, INC.2025-12-31Investor ClassMXMGX229,60017,102,903.940.8502
EMPOWER FUNDS, INC.2025-12-31Institutional ClassMXKWX36,7322,736,166.670.0296
This is a preview of the latest data. Subscribe to access the full data.